MedPath

LidoLite

LidoLite - Lidocaine Ointment USP 5% DO NOT USE IN THE EYES Rx Only

Approved
Approval ID

101e6544-6f24-4c56-8845-d0dcbcf18b10

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 17, 2023

Manufacturers
FDA

Forreal Pharmaceuticals LLC

DUNS: 118029197

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lidocaine

PRODUCT DETAILS

NDC Product Code81877-660
Application NumberANDA206498
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateNovember 17, 2023
Generic Namelidocaine

INGREDIENTS (3)

LIDOCAINEActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB
POLYETHYLENE GLYCOL 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
LidoLite - FDA Approval | MedPath